Sarcopenia and malnutrition in patients with liver diseases

Q4 Medicine Meditsinskiy Sovet Pub Date : 2023-11-03 DOI:10.21518/ms2023-374
A. S. Ostrovskaya, M. V. Maevskaya
{"title":"Sarcopenia and malnutrition in patients with liver diseases","authors":"A. S. Ostrovskaya, M. V. Maevskaya","doi":"10.21518/ms2023-374","DOIUrl":null,"url":null,"abstract":"This review focuses on the most current information on the pathogenesis, diagnosis and treatment of sarcopenia and malnutrition in patients with liver disease. Sarcopenia and malnutrition are common complications of liver diseases. Liver cirrhosis, as a stage of the pathological process, serves as the main predisposing factor for the development of malnutrition and sarcopenia. The frequency of sarcopenia in liver cirrhosis is 30–50% and reaches 100% in decompensated patients. The main pathogenetic links are: impaired proteostasis of skeletal muscles, systemic inflammation and changes in gut microbiota. In recent years, enough data have been accumulated to consider these conditions as a prognostically unfavorable factor in patients with liver cirrhosis of various etiologies, affecting their quality of life and survival, as well as worsening the out-comes of transplantation. This dictates the necessity to define unified approaches to diagnostics and correction of these conditions. Currently, tests are used for diagnosis, which allow to assess muscle strength and function. Muscle mass is assessed using instrumental methods by measuring individual muscles and calculating skeletal muscle indices. In patients with liver cirrhosis and concomitant sarcopenia and malnutrition, nutritional and lifestyle modification strategies are applicable for correction in addition to therapy aimed at elimination of the etiologic factor. The aim of the review is to evaluate the problems of diagnosis and effective treatment of malnutrition and sarcopenia in patients with liver disease based on literature data. The article presents an overview of the main strategies for the approach, diagnosis and correction of these conditions.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":"24 3","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Meditsinskiy Sovet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21518/ms2023-374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

This review focuses on the most current information on the pathogenesis, diagnosis and treatment of sarcopenia and malnutrition in patients with liver disease. Sarcopenia and malnutrition are common complications of liver diseases. Liver cirrhosis, as a stage of the pathological process, serves as the main predisposing factor for the development of malnutrition and sarcopenia. The frequency of sarcopenia in liver cirrhosis is 30–50% and reaches 100% in decompensated patients. The main pathogenetic links are: impaired proteostasis of skeletal muscles, systemic inflammation and changes in gut microbiota. In recent years, enough data have been accumulated to consider these conditions as a prognostically unfavorable factor in patients with liver cirrhosis of various etiologies, affecting their quality of life and survival, as well as worsening the out-comes of transplantation. This dictates the necessity to define unified approaches to diagnostics and correction of these conditions. Currently, tests are used for diagnosis, which allow to assess muscle strength and function. Muscle mass is assessed using instrumental methods by measuring individual muscles and calculating skeletal muscle indices. In patients with liver cirrhosis and concomitant sarcopenia and malnutrition, nutritional and lifestyle modification strategies are applicable for correction in addition to therapy aimed at elimination of the etiologic factor. The aim of the review is to evaluate the problems of diagnosis and effective treatment of malnutrition and sarcopenia in patients with liver disease based on literature data. The article presents an overview of the main strategies for the approach, diagnosis and correction of these conditions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肝病患者的肌肉减少和营养不良
本文综述了肝脏疾病患者肌肉减少症和营养不良的发病机制、诊断和治疗方面的最新进展。肌肉减少症和营养不良是肝脏疾病的常见并发症。肝硬化作为病理过程的一个阶段,是发展为营养不良和肌肉减少症的主要易感因素。肝硬化患者肌肉减少的发生率为30-50%,失代偿患者可达100%。主要的发病环节是:骨骼肌的蛋白质平衡受损,全身炎症和肠道微生物群的变化。近年来,已经积累了足够的数据,认为这些情况是各种病因肝硬化患者的预后不利因素,影响其生活质量和生存,并恶化移植结果。这就要求必须确定诊断和纠正这些病症的统一方法。目前,测试被用于诊断,它允许评估肌肉力量和功能。通过测量单个肌肉和计算骨骼肌指数,使用仪器方法评估肌肉质量。对于肝硬化并伴有肌肉减少症和营养不良的患者,除了旨在消除病因的治疗外,还可采用营养和生活方式改变策略进行矫正。本综述的目的是根据文献资料,评价肝病患者营养不良和肌肉减少症的诊断和有效治疗问题。文章介绍了主要策略的方法,诊断和纠正这些条件的概述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Meditsinskiy Sovet
Meditsinskiy Sovet Medicine-Medicine (all)
CiteScore
0.70
自引率
0.00%
发文量
418
审稿时长
6 weeks
期刊最新文献
Direct comparative study of the effectiveness of mepolizumab and dupilumab in patients with severe non-allergic eosinophilic asthma Possibilities of modern pharmacotherapy in patients with dysfunction of the sphincter of Oddi Microscopic colitis of incomplete collagen type in combination with lactase deficiency Approaches to the management of surgical patients with antibiotic-associated mild diarrhea Irritable bowel syndrome: modern ideas about pathology and the possibility of its correction
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1